EX-23.1 3 exhibit231.htm EX-23.1 exhibit231
 
 
Consent of Independent
 
Registered Public Accounting
 
Firm
We consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333- 273822)
and Form S-8 (Nos. 333-271486 and 333-261061) of Vaxxinity,
 
Inc. (the "Company") of our report dated
March 27, 2024, with respect to the consolidated financial statements of the Company included in this
Annual Report on Form 10-K for the year ended December 31, 2023. Our report contains an explanatory
paragraph describing conditions that raise substantial doubt about the Company's ability to continue as a
going concern. The consolidated financial statements do not include any adjustments that might result from
the outcome of this uncertainty.
/s/ FORVIS, LLP
New York, New York
March 27, 2024